Does RUXOLITINIB Cause Hepatic function abnormal? 166 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Hepatic function abnormal have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
166
Reports of Hepatic function abnormal with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
52
Deaths
80
Hospitalizations
How Dangerous Is Hepatic function abnormal From RUXOLITINIB?
Of the 166 reports, 52 (31.3%) resulted in death, 80 (48.2%) required hospitalization, and 17 (10.2%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 166 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which RUXOLITINIB Alternatives Have Lower Hepatic function abnormal Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE